FDA-Aligned Caution (Required Context):FDA safety context (GLP-1 compounding): The FDA has warned about dosing errors associated with compounded injectable semaglutide and noted that some compounders may use salt forms (such as semaglutide sodium or semaglutide acetate)
Novo Nordisk may have first-mover advantage in the oral space, with oral Wegovy (obesity) and Rybelsus (T2D, launched 2019), but orforglipron is expected to outperform these on-market semaglutide options for a number of reasons: superior HbA1c reduction and weight loss
If you're living with Type 2 Diabetes, Obesity, PCOS/PCOD, Fatty Liver, Hypertension, High Uric Acid, or GERD, it's time to take the first step towards better health
SURMOUNT-1 (tirzepatide) Clinical Trial: Fat-mass loss predominates across subgroups
Those given the supplement lost 11.9 pounds (5.4 kg) over 16 weeks, compared to only 2 pounds (0.9 kg) in the placebo group
Following bariatric surgery, particularly procedures that alter gastric anatomy and intestinal transit, the normal physiological regulation of glucose homeostasis becomes disrupted
